Drug interactions include: * Co-administration with strong inhibitors of the liver enzyme CYP3A4 (e.g. ketoconazole, ritonavir, clarithromycin, grapefruit juice) may increase<unk>  serum levels as it is a CYP3A4 substrate. * CYP3A4 inducers (e.g. rifampin, carbamazepine) decrease<unk>  serum levels. * It is a p-glycoprotein (PGP) substrate and hence PGP inhibitors such as quinidine may interact with<unk> . *<unk>  is not a substrate for either of the liver enzymes OATP1B1 and OATP1B3. *<unk>  has inhibitory potency towards OATP1B1 but not for OATP1B3.
Pazopanib
Vatalanib
Pegaptanib
Tivozanib
Nintedanib
Abrocitinib
Gilteritinib
Erdafitinib